Neuberger Berman Group LLC Buys 336,982 Shares of Kenvue Inc. $KVUE

Neuberger Berman Group LLC boosted its stake in Kenvue Inc. (NYSE:KVUE) by 19.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,026,137 shares of the company’s stock after purchasing an additional 336,982 shares during the quarter. Neuberger Berman Group LLC’s holdings in Kenvue were worth $32,884,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in KVUE. Cornerstone Planning Group LLC lifted its position in shares of Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after buying an additional 1,361 shares in the last quarter. NBT Bank N A NY grew its holdings in Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares in the last quarter. Salomon & Ludwin LLC purchased a new position in Kenvue during the 3rd quarter valued at approximately $25,000. Golden State Wealth Management LLC increased its stake in Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after acquiring an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont raised its holdings in shares of Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on KVUE shares. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and cut their target price for the company from $23.00 to $18.00 in a report on Friday, January 30th. Canaccord Genuity Group boosted their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. UBS Group upped their target price on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Barclays increased their price target on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Friday. Finally, Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat.com, Kenvue currently has an average rating of “Hold” and an average price target of $19.58.

Kenvue Stock Up 0.9%

NYSE KVUE opened at $18.41 on Friday. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The firm has a market capitalization of $35.29 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 4.21 and a beta of 0.51. The company has a fifty day moving average of $17.85 and a two-hundred day moving average of $17.43.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business’s revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the business earned $0.26 EPS. On average, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.5%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is 107.79%.

Insider Activity at Kenvue

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the business’s stock in a transaction dated Friday, December 12th. The shares were purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the purchase, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. This represents a 13.27% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 1.68% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.